Acalabrutinib D4 is a deuterium-labeled version of acalabrutinib, a pharmaceutical compound used in research and pharmaceutical manufacturing. Its structure incorporates four deuterium atoms on the pyridine ring, which aids in analytical studies.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2699608-18-7
Pristinamycin
pharmaceutical raw material
17-Hydroxy-1a,2a-methylenepregna-4,6-diene-3,20-dione acetate
pharmaceutical raw material
Oxiglutatione
pharmaceutical raw material
Tilidine hydrochloride
pharmaceutical raw material
Acalabrutinib
pharmaceutical raw material
Acalabrutinib enantiomer
pharmaceutical raw material
Acalabrutinib maleate
pharmaceutical raw material
Calquence
pharmaceutical raw material
4-[8-amino-3-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-(3,4,5,6-tetradeuterio-2-pyridinyl)benzamide
WDENQIQQYWYTPO-FJSIYNKGSA-N
[2H]C1=C(C(=NC(=C1[2H])NC(=O)C2=CC=C(C=C2)C3=C4C(=NC=CN4C(=N3)[C@@H]5CCCN5C(=O)C#CC)N)[2H])[2H]